Trial record 13 of 54 for:    Insomnia | Open Studies | NIH, U.S. Fed

Acupuncture for the Treatment of Insomnia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by University of Pittsburgh.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Ronald M. Glick, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00855140
First received: March 2, 2009
Last updated: June 14, 2012
Last verified: June 2012
  Purpose

Insomnia is a common and disabling condition associated with psychiatric and medical comorbidities and often persists despite currently available treatments. Acupuncture has been reported to benefit individuals with insomnia and can decrease hyperarousal. This blinded RCT will investigate the impact of a standardized acupuncture protocol on insomnia, daytime symptoms, and hyperarousal.


Condition Intervention Phase
Primary Insomnia
Other: Acupuncture
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Acupuncture for the Treatment of Insomnia - A Pilot Study

Resource links provided by NLM:


Further study details as provided by University of Pittsburgh:

Primary Outcome Measures:
  • Sleep efficiency on polysomnography [ Time Frame: Baseline and post-intervention ] [ Designated as safety issue: No ]
  • Pittsburgh Sleep Quality Index (PSQI) [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]
  • Insomnia Severity Index (ISI) [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Epworth Sleepiness Scale (ESS) [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]
  • Multidimensional Fatigue Inventory (MFI) [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]
  • Inventory for Depressive Symptomatology—Self-Rated (IDS-SR) [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]
  • State version of the Spielberger State-Trait Anxiety Inventory (STAI-s) [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]
  • The Pre-Sleep Arousal Scale (PSAS) [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]
  • Pittsburgh Sleep Diary (PghSD) and actigraphy recording [ Time Frame: Baseline, EOI, & 3 months post-tx ] [ Designated as safety issue: No ]
  • Adverse event form (AEF) [ Time Frame: Weekly during the intervention period & EOI ] [ Designated as safety issue: Yes ]
  • Autonomic arousal as measured by HRV & Q-EEG during sleep recording [ Time Frame: Baseline & EOI ] [ Designated as safety issue: No ]

Estimated Enrollment: 56
Study Start Date: March 2009
Estimated Study Completion Date: February 2013
Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Sham acupuncture Other: Acupuncture
Acupuncture, derived from the TCM literature, specific for insomnia
Experimental: Verum Acupuncture Other: Acupuncture
Acupuncture, derived from the TCM literature, specific for insomnia

Detailed Description:

Insomnia is a common problem that is disabling and that frequently persists despite available medical and behavioral approaches. It is associated significant psychiatric and medical comorbidities and high medical and societal costs. Benzodiazepine receptor agonists (BzRA's) and cognitive behavioral therapies are common treatments, but despite these, insomnia remains a pervasive problem. Complementary and alternative medicine (CAM) treatments are being used widely for the treatment of insomnia, but many of these modalities have sparse research support. There are numerous reports in the Traditional Chinese Medicine (TCM)literature of dramatic benefits of acupuncture for the treatment of insomnia, but carefully designed studies are limited. Insomnia has been associated with hyperarousal and acupuncture has documented effects on autonomics with a shift towards parasympathetic predominance. In consultation with experts in acupuncture and TCM, we developed a protocol for the treatment of insomnia and have used it clinically with good success.

We will be conducting a 3-year exploratory pilot randomized-controlled blinded trial (RCT) of this protocol on 56 adults with insomnia disorder, utilizing a control condition involving placement of placebo needles. We seek to determine the effect size of this acupuncture intervention in comparison to the control condition in preparation for a more definitive study, with the future primary aim to determine if acupuncture is effective and well tolerated in the treatment of insomnia. Measures will include self-report and objective measures of sleep quality and duration including polysomnography (PSG). Secondary-exploratory aims will be to determine the impact of this acupuncture protocol on daytime symptoms of insomnia such as fatigue, anxiety, and depression as well as to explore the impact of acupuncture on self-report and objective measures of hyperarousal.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Ages 18-60;
  2. Ability to speak, read, and write English;
  3. Insomnia disorder, as defined by RDC, of 3 months or greater duration.

Exclusion Criteria:

  1. Presence of serious psychiatric Axis I DSM-IV disorders such as bipolar or psychotic disorders—as individuals with conditions may respond differently than insomnia disorder to the acupuncture intervention, potentially confounding the results;
  2. Active suicidal ideation or active psychosis, as this may present a concern regarding safety for a subject's participation in this study;
  3. Presence of depressive or anxiety disorders of moderate or greater severity based on either HAM-D scores or HAM-A scores of 14 or greater;
  4. Presence of unstable medical conditions commonly associated with significant sleep disturbance, e.g. uncompensated congestive heart failure, as this would not be expected to respond to the acupuncture intervention;
  5. Presence of other sleep disorder, such as periodic limb movement disorder or sleep apnea, as these conditions would require other medical treatment—this will be based on known history of sleep disorder or findings on screening PSG of apnea-hypopnea index of > 10 or periodic limb movement index of >10;
  6. Alcohol use > 14 beverages/week, as this may impact on response to the intervention and assessment measures;
  7. Ongoing use of any recreational drugs;
  8. Ongoing use of benzodiazepines, prescription hypnotic medication, over-the-counter hypnotic medication, or nutritional supplements with purported hypnotic effects;
  9. Ongoing use of other psychotropic medication, such as psychostimulants, or antipsychotics;
  10. Caffeine use > the equivalent of 5 cups of coffee/day;
  11. Pregnancy, as the safe use of acupuncture in pregnancy has not been established;
  12. Active malignancy, autoimmune condition, or treatment with immunosuppressive drugs;
  13. Presence of coagulopathy or use of anticoagulant medication;
  14. Active involvement in any psychotherapy or other treatment specifically directed towards insomnia;
  15. Prior experience with acupuncture treatment in the last 6 months or prior participation in an acupuncture research study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00855140

Contacts
Contact: Chelsea Lamberg 412-623-3811 lambergck@upmc.edu
Contact: Christine McFarland 412-623-6872 mcfarlandce@upmc.edu

Locations
United States, Pennsylvania
Center for Integrative Medicine at UPMC Shadyside Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Christine McFarland    412-623-6872    mcfarlandce@upmc.edu   
Sub-Investigator: Buysse Daniel, MD         
Sub-Investigator: Cheng Yu, PhD         
Sub-Investigator: Cohen Susan, PhD         
Sub-Investigator: Hall Martica, PhD         
Sub-Investigator: Ryan Neal, MD         
Principal Investigator: Glick M Ronald, MD         
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: Ronald M Glick, MD University of Pittsburgh
  More Information

No publications provided

Responsible Party: Ronald M. Glick, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00855140     History of Changes
Other Study ID Numbers: 1R21AT004429-01A1, 1R21AT004429-01A1
Study First Received: March 2, 2009
Last Updated: June 14, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
Insomnia
Primary insomnia
Insomnia disorder
Acupuncture

ClinicalTrials.gov processed this record on October 29, 2014